Privia Health Group’s (PRVA) “Market Outperform” Rating Reiterated at JMP Securities

JMP Securities restated their market outperform rating on shares of Privia Health Group (NASDAQ:PRVA) in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a $26.00 target price on the stock.

Several other equities research analysts also recently commented on PRVA. Truist Financial lifted their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. JPMorgan Chase & Co. boosted their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th. Stephens restated an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a research note on Thursday, January 2nd. Barclays boosted their price target on shares of Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, November 8th. Finally, Macquarie assumed coverage on shares of Privia Health Group in a research note on Monday, December 16th. They set an “outperform” rating and a $25.00 price target for the company. Two analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $24.94.

Privia Health Group Price Performance

NASDAQ:PRVA opened at $25.24 on Friday. The firm’s 50 day simple moving average is $21.62 and its 200 day simple moving average is $20.23. Privia Health Group has a one year low of $15.92 and a one year high of $25.49. The company has a market cap of $3.03 billion, a PE ratio of 252.43, a P/E/G ratio of 3.07 and a beta of 0.87.

Hedge Funds Weigh In On Privia Health Group

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Northern Trust Corp boosted its holdings in shares of Privia Health Group by 14.2% in the 4th quarter. Northern Trust Corp now owns 1,392,641 shares of the company’s stock worth $27,226,000 after buying an additional 173,563 shares during the last quarter. Tudor Investment Corp ET AL lifted its holdings in Privia Health Group by 16.5% during the fourth quarter. Tudor Investment Corp ET AL now owns 267,899 shares of the company’s stock valued at $5,237,000 after purchasing an additional 37,904 shares during the last quarter. Two Sigma Securities LLC purchased a new stake in Privia Health Group during the fourth quarter valued at about $463,000. Voya Investment Management LLC lifted its holdings in Privia Health Group by 4.7% during the fourth quarter. Voya Investment Management LLC now owns 212,342 shares of the company’s stock valued at $4,151,000 after purchasing an additional 9,539 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its holdings in Privia Health Group by 15.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 73,416 shares of the company’s stock valued at $1,436,000 after purchasing an additional 9,880 shares during the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.